HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Richard F Kefford Selected Research
Richard F Kefford Research Topics
Disease
97
Melanoma (Melanoma, Malignant)
01/2023 - 03/2003
44
Neoplasms (Cancer)
11/2020 - 02/2003
14
Neoplasm Metastasis (Metastasis)
01/2023 - 07/2012
10
Disease Progression
12/2015 - 06/2007
6
Brain Neoplasms (Brain Tumor)
01/2021 - 05/2012
3
Nevus (Nevi)
11/2011 - 08/2009
3
Pancreatic Neoplasms (Pancreatic Cancer)
07/2007 - 10/2006
2
Uveal melanoma
11/2018 - 10/2006
2
Fever (Fevers)
10/2014 - 11/2012
2
Nervous System Neoplasms (Neoplasms, Nervous System)
07/2007 - 12/2006
1
Monosomy
11/2018
1
Hemolysis
04/2016
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
04/2016
1
Adenocarcinoma
04/2015
1
Arthritis (Polyarthritis)
01/2015
1
Tenosynovitis
01/2015
1
Sarcoma (Soft Tissue Sarcoma)
10/2014
1
Acneiform Eruptions
10/2014
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014
1
Keratosis
10/2014
1
Facial Paralysis (Facial Palsy)
04/2013
1
Carcinogenesis
12/2012
1
Neutropenia
11/2012
Drug/Important Bio-Agent (IBA)
22
dabrafenib
IBA
01/2019 - 03/2012
16
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2017 - 07/2012
13
trametinib
IBA
01/2020 - 11/2012
9
Immune Checkpoint Inhibitors
IBA
01/2023 - 08/2015
9
Biomarkers (Surrogate Marker)
IBA
01/2020 - 05/2012
9
Vemurafenib
IBA
12/2015 - 03/2012
9
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
02/2010 - 02/2003
8
Proteins (Proteins, Gene)
FDA Link
01/2018 - 02/2009
7
DNA (Deoxyribonucleic Acid)
IBA
08/2020 - 03/2003
6
Phosphotransferases (Kinase)
IBA
01/2020 - 12/2014
6
Cyclin-Dependent Kinase Inhibitor p16
IBA
11/2011 - 10/2008
5
Circulating Tumor DNA
IBA
08/2020 - 01/2018
5
Mitogen-Activated Protein Kinases
IBA
01/2020 - 07/2013
5
Antibodies
IBA
01/2018 - 07/2012
3
Cytokines
IBA
01/2023 - 03/2014
3
Paraffin
IBA
01/2019 - 01/2013
3
Formaldehyde (Formol)
FDA Link
01/2019 - 01/2013
3
Nivolumab
IBA
09/2017 - 04/2016
3
pembrolizumab
IBA
09/2017 - 01/2015
3
Type 1 Melanocortin Receptor
IBA
09/2013 - 03/2003
2
Cell-Free Nucleic Acids
IBA
08/2020 - 09/2013
2
RNA (Ribonucleic Acid)
IBA
01/2020 - 01/2018
2
Interferons
IBA
01/2018 - 03/2017
2
Ipilimumab
IBA
01/2018 - 04/2016
2
Catenins
IBA
10/2017 - 01/2014
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
03/2016 - 03/2010
2
Cyclin-Dependent Kinases (cdk Proteins)
IBA
03/2013 - 11/2005
2
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
08/2009 - 07/2007
1
Histocompatibility Antigens Class I
IBA
11/2020
1
Antigens
IBA
11/2020
1
Immune Checkpoint Proteins
IBA
01/2020
1
Dual Specificity Phosphatase 6
IBA
01/2019
1
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
11/2018
1
RNA Splicing Factors
IBA
11/2018
1
Peptide Initiation Factors (Initiation Factor)
IBA
11/2018
1
Programmed Cell Death 1 Receptor
IBA
01/2018
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2018
1
encorafenib
IBA
09/2017
1
Blood Proteins (Serum Proteins)
IBA
01/2017
1
Monoclonal Antibodies
IBA
04/2016
1
Isoantibodies
IBA
04/2016
1
tributyl phosphate (TBP)
IBA
10/2014
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2014
1
Steroids
IBA
10/2014
1
Acetaminophen (Paracetamol)
FDA Link
Generic
10/2014
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
10/2014
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
09/2014
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2014
1
Chemokines
IBA
03/2014
1
nilotinib
FDA Link
07/2013
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
07/2013
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2013
1
Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)
IBA
07/2013
1
Cadherins (E-Cadherin)
IBA
05/2013
1
A-Form DNA (A-DNA)
IBA
03/2013
1
thiamine triphosphorate (TTP)
IBA
01/2013
1
Lipase (Acid Lipase)
FDA Link
11/2012
1
Amylases
FDA Link
11/2012
1
Proto-Oncogene Proteins B-raf
IBA
07/2012
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
03/2012
1
Granzymes (Granzyme)
IBA
03/2012
1
PLX 4720
IBA
03/2012
1
Microphthalmia-Associated Transcription Factor
IBA
11/2011
1
CI 22
IBA
04/2011
1
Dacarbazine (DIC)
FDA Link
Generic
03/2010
1
Bosentan (Tracleer)
FDA Link
03/2010
1
Endothelin Receptor Antagonists
IBA
03/2010
1
Endothelins (Endothelin)
IBA
03/2010
1
interleukin-21 (interleukin 21)
IBA
03/2009
Therapy/Procedure
34
Therapeutics
01/2023 - 02/2005
10
Immunotherapy
01/2023 - 03/2010
4
Drug Therapy (Chemotherapy)
01/2021 - 06/2007
2
Aftercare (After-Treatment)
10/2014 - 03/2012
1
Radiotherapy
01/2021
1
Neoadjuvant Therapy
01/2019
1
Drug Tapering
10/2014
1
Precision Medicine
12/2012